Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Titan’s Probuphine Dosing May Need Review, FDA Staff Says
Titan’s Probuphine Dosing May Need Review, FDA Staff Says
Titan’s Probuphine Dosing May Need Review, FDA Staff Says
Submitted by
admin
on March 19, 2013 - 11:17am
Source:
Bloomberg
News Tags:
Titan Pharmaceuticals
FDA
Probuphine
addiction
Headline:
Titan’s Probuphine Dosing May Need Review, FDA Staff Says
Do Not Allow Advertisers to Use My Personal information
